An EU expert panel backed Eli Lilly’s Foundayo application for marketing authorization.
Foundayo is a pill containing orforglipron. The recommendation brings it closer to possible approval in Europe.
Health
Add as a preferred source on GoogleFoundayo Advances in EU Review After Expert Panel Recommendation
Foundayo is a tablet containing orforglipron, and the panel’s backing brings it nearer to possible EU authorization.
Updated 1 min read
Related articles
Health
Lilly, Hims & Hers Agree on Platform Access to Two Weight-Loss Drugs
Zepbound self-pay prices start at $299 a month and Foundayo at $149; the companies did not announce a launch date.
Politics
European Officials Push Back on U.S. Security Plan for Ukraine
Kaja Kallas said the EU must take part in implementing an agreement, while Polish and Ukrainian officials objected to decisions made over their heads and Moscow acting as Europe’s security guarantor.
Law
Spain’s Rail Safety Upgrades Draw Second EU Fraud Probe
The European Public Prosecutor’s Office says investigators are active at three Spanish public bodies; a separate March case focused on track-maintenance funding.